After the U.S. government supports a proposal to abandon intellectual property protection
Mexico City- After the US government supported a proposal to abandon the protection of intellectual property rights for vaccines and medicines against Covid-19, global pharmaceutical companies pointed out that this measure will undermine the global response to the pandemic, further weaken the supply chain, and will not save lives. .
The International Federation of Pharmaceutical Industries (IFPMA) is a trade association representing companies such as AstraZeneca, Bayer, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck, MSD, Pfizer and Sanofi. It believes that it supports the temporary cancellation of patents. The decision to treat the anti-Covid vaccine is “disappointing”.
He said in a statement: “We fully agree with the goal of fair and reasonable distribution of the Covid-19 vaccine worldwide. However, as we have always said, stopping the drug is a simple but incorrect answer to complex problems. “The lobby group is based in Geneva, Switzerland.
Similarly, the Pharmaceutical Researchers and Producers Association of America (PhRMA) also warned that the decision will facilitate this decision. The association’s member laboratories include AstraZeneca, Pfizer, Boehringer Ingelheim, Eli Lilly, and GlaxoSmithKline. , Merck, Novartis and Sanofi. The spread of counterfeit vaccines.
“In the deadly pandemic, the Biden administration has taken unprecedented steps that will undermine our global response to the pandemic and endanger security. This decision will cause chaos between public and private partners, further weakening already tense Supply chain and encourage proliferation,” said Stephen J. Ubl, President and CEO of American Pharmaceutical Research and Manufacturers.
He added: “This long-term change in U.S. policy will not save lives. This is also in line with President Biden’s proposal to build U.S. infrastructure and provide U.S. innovative technologies to countries that try to undermine our leadership in biomedical discovery. The job creation policy runs counter to the policy.” Written statement.
PhRMA called Biden’s promise “empty” and pointed out that since 2000, member companies of the association have invested nearly $1 billion in the search for new therapies and therapies.
PhRMA said in a statement: “In the past few days alone, we have seen an increase in US vaccine exports, manufacturers’ increased production targets, new commitments to COVAX and unprecedented support for India’s devastating Covid-19 growth. “
“Biopharmaceutical manufacturers are fully committed to providing global access to the Covid-19 vaccine and are collaborating on an unprecedented scale.”
Katherine Tai, the U.S. Trade Representative, previously believed that the world’s supply of vaccines must be expanded to end the coronavirus pandemic and promote recovery.
Tayden said that the Biden administration will now actively participate in the negotiations of the World Trade Organization (WTO) patent exemption text and will encourage other countries to support the text.
He said in an interview on Wednesday: “We are in favor of the WTO’s exemption, and our supporters of the exemption are striving to achieve the goal, that is, better access, more production capacity, and more vaccination.”